CK21

General Information


DRACP ID  DRACP03597

Peptide Name   CK21

Sequence  CNGRCGGKLAKLAKKLAKLAK

Sequence Length  21

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C94H175N31O23S2

Absent amino acids  DEFHIMPQSTVWY

Common amino acids  K

Mass  252869

Pl  11.09

Basic residues  7

Acidic residues  0

Hydrophobic residues  8

Net charge  7

Boman Index  -2256

Hydrophobicity  -24.76

Aliphatic Index  93.33

Half Life 
  Mammalian: 1 hour
  Yeast: 2 min
  E.coli: 2 min

Extinction Coefficient cystines  125

Absorbance 280nm  6.25

Polar residues  6

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 25990455

Title  An antimicrobial peptide containing NGR motif has potent antitumor activity against CD13+ and CD13- tumor cells

Doi Not available

Year  2015

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  8125

DRACP is developed by Dr.Zheng's team.